Literature DB >> 19244378

A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands.

Jessica R Lieffers1, Marina Mourtzakis, Kevin D Hall, Linda J McCargar, Carla M M Prado, Vickie E Baracos.   

Abstract

BACKGROUND: Cancer cachexia-associated weight loss is poorly understood; energetically demanding tissues (eg, organ and tumor mass) and resting energy expenditure (REE) are reported to increase with advanced cancer.
OBJECTIVE: The objective was to quantify the potential contribution of increasing masses of energetically demanding tissues to REE with colorectal cancer cachexia progression.
DESIGN: A longitudinal computed tomography (CT) image review was performed to quantify organ size (liver, including metastases, and spleen) and peripheral tissues (skeletal muscle and adipose tissue) during colorectal cancer cachexia progression (n = 34). Body composition was prospectively evaluated by CT and dual-energy X-ray absorptiometry, and REE was determined by indirect calorimetry in advanced colorectal cancer patients (n = 18).
RESULTS: Eleven months from death, the liver (2.3 +/- 0.7 kg) and spleen (0.32 +/- 0.2 kg) were larger than reference values. One month from death, liver weight increased to 3.0 +/- 1.5 kg (P = 0.010), spleen showed a trend to increase (P = 0.077), and concurrent losses of muscle (4.2 kg) and fat (3.5 kg) (P < 0.05) were observed. The estimated percentage of fat-free mass (FFM) occupied by the liver increased from 4.5% to 7.0% (P < 0.001). The most rapid loss of peripheral tissues and liver and metastases gain occurred within 3 mo of death. A positive linear relation existed between liver mass and measured whole-body REE (r(2) = 0.35, P = 0.010); because liver accounted for a larger percentage of FFM, measured REE . kg FFM(-1) . d(-1) increased (r(2) = 0.35, P = 0.010).
CONCLUSIONS: Increases in mass and in the proportion of high metabolic rate tissues, including liver and tumor, represented a cumulative incremental REE of approximately 17,700 kcal during the last 3 mo of life and may contribute substantially to cachexia-associated weight loss.

Entities:  

Mesh:

Year:  2009        PMID: 19244378      PMCID: PMC2667460          DOI: 10.3945/ajcn.2008.27273

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  30 in total

1.  Metabolically active components of fat free mass and resting energy expenditure in nonobese adults.

Authors:  K Illner; G Brinkmann; M Heller; A Bosy-Westphal; M J Müller
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-02       Impact factor: 4.310

2.  The effect of tumor bulk on the metabolic response to cancer.

Authors:  J B Koea; J H Shaw
Journal:  Ann Surg       Date:  1992-03       Impact factor: 12.969

Review 3.  Growth rate and percentage hepatic replacement of colorectal liver metastases.

Authors:  S F Purkiss; N S Williams
Journal:  Br J Surg       Date:  1993-08       Impact factor: 6.939

4.  Visceral adipose tissue: relations between single-slice areas and total volume.

Authors:  Wei Shen; Mark Punyanitya; ZiMian Wang; Dympna Gallagher; Marie-Pierre St-Onge; Jeanine Albu; Steven B Heymsfield; Stanley Heshka
Journal:  Am J Clin Nutr       Date:  2004-08       Impact factor: 7.045

5.  Measurements of resting energy expenditure and body composition before and after treatment of small cell lung cancer.

Authors:  S A Jebb; R J Osborne; A K Dixon; N M Bleehen; M Elia
Journal:  Ann Oncol       Date:  1994-12       Impact factor: 32.976

6.  Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer.

Authors:  J S Falconer; K C Fearon; C E Plester; J A Ross; D C Carter
Journal:  Ann Surg       Date:  1994-04       Impact factor: 12.969

7.  [Respiratory gas exchange and glucose uptake by the human spleen in situ (author's transl)].

Authors:  P Vaupel; P Wendling; H Thomé; T J Fischer
Journal:  Klin Wochenschr       Date:  1977-03-01

8.  Acute-phase protein response and survival duration of patients with pancreatic cancer.

Authors:  J S Falconer; K C Fearon; J A Ross; R Elton; S J Wigmore; O J Garden; D C Carter
Journal:  Cancer       Date:  1995-04-15       Impact factor: 6.860

9.  Tissue components of weight loss in cancer patients. A new method of study and preliminary observations.

Authors:  S B Heymsfield; C B McManus
Journal:  Cancer       Date:  1985-01-01       Impact factor: 6.860

10.  Energy balance in patients with advanced NSCLC, metastatic melanoma and metastatic breast cancer receiving chemotherapy--a longitudinal study.

Authors:  M N Harvie; A Howell; N Thatcher; A Baildam; I Campbell
Journal:  Br J Cancer       Date:  2005-02-28       Impact factor: 7.640

View more
  83 in total

1.  Total energy expenditure in patients with colorectal cancer: associations with body composition, physical activity, and energy recommendations.

Authors:  Sarah A Purcell; Sarah A Elliott; Peter J Walter; Tom Preston; Hongyi Cai; Richard J E Skipworth; Michael B Sawyer; Carla M Prado
Journal:  Am J Clin Nutr       Date:  2019-08-01       Impact factor: 7.045

2.  Change in Skeletal Muscle Following Resection of Stage I-III Colorectal Cancer is Predictive of Poor Survival: A Cohort Study.

Authors:  Jessica J Hopkins; Rebecca Reif; David Bigam; Vickie E Baracos; Dean T Eurich; Michael M Sawyer
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

Review 3.  Key determinants of energy expenditure in cancer and implications for clinical practice.

Authors:  S A Purcell; S A Elliott; V E Baracos; Q S C Chu; C M Prado
Journal:  Eur J Clin Nutr       Date:  2016-06-08       Impact factor: 4.016

Review 4.  Research priorities in cancer cachexia: The University of Rochester Cancer Center NCI Community Oncology Research Program Research Base Symposium on Cancer Cachexia and Sarcopenia.

Authors:  Richard F Dunne; Karen M Mustian; Jose M Garcia; William Dale; Reid Hayward; Breton Roussel; Mary M Buschmann; Bette J Caan; Calvin L Cole; Fergal J Fleming; Joe V Chakkalakal; David C Linehan; Aram F Hezel; Supriya G Mohile
Journal:  Curr Opin Support Palliat Care       Date:  2017-12       Impact factor: 2.302

5.  The Impact of Early Referrals to Dietitians for Patients With Esophagogastric Cancer.

Authors:  Eric J Roeland; Richard F Dunne
Journal:  J Natl Compr Canc Netw       Date:  2021-02-02       Impact factor: 11.908

Review 6.  Cancer cachexia, recent advances, and future directions.

Authors:  Marie-France Penet; Zaver M Bhujwalla
Journal:  Cancer J       Date:  2015 Mar-Apr       Impact factor: 3.360

Review 7.  Chemotherapy-Induced Sarcopenia.

Authors:  Federico Bozzetti
Journal:  Curr Treat Options Oncol       Date:  2020-01-30

Review 8.  The role of computed tomography in evaluating body composition and the influence of reduced muscle mass on clinical outcome in abdominal malignancy: a systematic review.

Authors:  D J Gibson; S T Burden; B J Strauss; C Todd; S Lal
Journal:  Eur J Clin Nutr       Date:  2015-03-18       Impact factor: 4.016

9.  Weight loss versus muscle loss: re-evaluating inclusion criteria for future cancer cachexia interventional trials.

Authors:  Eric J Roeland; Joseph D Ma; Sandahl H Nelson; Tyler Seibert; Sean Heavey; Carolyn Revta; Andrea Gallivan; Vickie E Baracos
Journal:  Support Care Cancer       Date:  2016-09-15       Impact factor: 3.603

Review 10.  Nutritional systems biology modeling: from molecular mechanisms to physiology.

Authors:  Albert A de Graaf; Andreas P Freidig; Baukje De Roos; Neema Jamshidi; Matthias Heinemann; Johan A C Rullmann; Kevin D Hall; Martin Adiels; Ben van Ommen
Journal:  PLoS Comput Biol       Date:  2009-11-26       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.